How does 30 new AFib
patients in 100 days
sound to you?
from Illinois' Best!
Leading cardiac centers use our technology to acquire
new AFib patients with a 3X return-on-investment.
Cardiology & Heart Surgery program.
from Illinois' Best!
Cardiology & Heart Surgery program.
from Illinois' Best!
How does 30 new AFib
patients in 100 days
sound to you?
Cardiology & Heart Surgery program.
Leading cardiac centers use our technology to acquire
new AFib patients with a 3X return-on-investment.
from Illinois' Best!
Cardiology & Heart Surgery program.
How does 30 new AFib patients
in 100 days sound to you?
How does 30 new AFib patients
in 100 days sound to you?
How does 30 new AFib
patients in 100 days
sound to you?
Leading cardiac centers use our technology to acquire
new AFib patients with a 3X return-on-investment.
Leading cardiac centers use our technology to acquire new AFib patients with a 3X return-on-investment.
You may qualify for a new, safe and
effective treatment for atrial fibrillation.
Our clients know AFib is a
strategic growth opportunity
Our clients know AFib is a strategic growth opportunity
Our clients know AFib is a
strategic growth opportunity
Our clients know AFib is a
strategic growth opportunity
Our clients know AFib is a strategic growth opportunity
struggle with atrial fibrillation
struggle with atrial fibrillation
rate in United States in 10 years
rate in United States in 10 years
in the United States by 2030
in the United States by 2030
Our clients know AFib is a
strategic growth opportunity
Our clients know AFib is a strategic growth opportunity
Our clients know AFib is a
strategic growth opportunity
Our clients know AFib is a
strategic growth opportunity
Our clients know AFib is a strategic growth opportunity
struggle with atrial fibrillation
struggle with atrial fibrillation
rate in United States in 10 years
rate in United States in 10 years
in the United States by 2030
in the United States by 2030
In just 18 minutes, our technology can locate, pre-screen and schedule new AFib patients at your cardiac center.
In just 18 minutes, our technology can locate, pre-screen and schedule new AFib patients at your cardiac center.
In just 18 minutes, our technology can locate,
pre-screen and schedule new AFib patients
at your cardiac center.
In just 18 minutes, our technology can locate,
pre-screen and schedule new AFib patients
at your cardiac center.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our novel
approach to new patient acquisition.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our
novel approach to new
patient acquisition.
Unlike other digital agencies, our team focuses solely on
new patient acquisition for atrial fibrillation. During the
past 5 years, we have acquired over 7,000 patients for
commercial AFib therapies (cardioversion, ablation,
Watchman, Maze procedure) or clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for atrial fibrillation. During the past 5 years, we have acquired over 7,000 patients for commercial AFib therapies (cardioversion, ablation, Watchman, Maze procedure) or clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for atrial fibrillation. During the past 4 years, we generated over 5,000 patient inquiries for commercial AFib therapies (medications, cardioversion, catheter ablation, pacemaker, left atrial appendage occlusion, Maze procedure) and clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for atrial fibrillation. During the past 5 years, we have acquired over 7,000 patients for commercial AFib therapies (cardioversion, ablation, Watchman, Maze procedure) or clinical trials.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our novel approach to new patient acquisition.
Achieve a 3X ROI using our
novel approach to new
patient acquisition.
Unlike other digital agencies, our team focuses solely on new
patient acquisition for atrial fibrillation. During the past
4 years, we have generated over 5,000 patient inquiries
for
commercial AFib therapies (medications, cardioversion, catheter ablation, pacemaker, left atrial appendage
occlusion, Maze procedure) and clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for atrial fibrillation. During the past 4 years, we generated over 5,000 patient inquiries for commercial AFib therapies (medications, cardioversion, catheter ablation, pacemaker, left atrial appendage occlusion, Maze procedure) and clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for atrial fibrillation. During the past 5 years, we have acquired over 7,000 patients for commercial AFib therapies (cardioversion, ablation, Watchman, Maze procedure) or clinical trials.
Unlike other digital agencies, our team focuses solely on new patient acquisition for atrial fibrillation. During the past 4 years, we generated over 5,000 patient inquiries for commercial AFib therapies (medications, cardioversion, catheter ablation, pacemaker, left atrial appendage occlusion, Maze procedure) and clinical trials.
Dominate your AFib
market like our clients
Dominate your AFib
market like our clients
Dominate your AFib market like our clients
Dominate your AFib market like our clients
Dominate your AFib market like our clients
"In a very quick timeframe, NewAFibPatients developed and launched an effective,
turn-key platform for patient education and recruitment at Northwestern Medicine. We
are very happy with the early results and it continues to improve."
- Dr. Patrick McCarthy
Executive Director of the Bluhm Cardiovascular Institute and
Chief of Cardiac Surgery, Northwestern Medicine
"Just 90 days after launching its interactive platform for our AFib clinical trial, we received
913 patient inquiries, 477 online screening passes and 111 qualified patients were transferred
to our clinical sites. This technology has transformed AtriCure's approach
to digital patient recruitment for clinical trials."
- Shana Zink
Former Vice President, Clinical Affairs
AtriCure (NASDAQ: ATRC)
Consider this 100-day case study
for a Top 10 cardiac center
We are different. While traditional digital agencies use
impressions to exaggerate reach, our technology reports
new patient registrations and verified billable events
to demonstrate tangible ROI.
As a client, you will have 24/7/365 access to an interactive
dashboard that provides key performance indicators and
real-time patient acquisition funnels. For example, the results
on the right are for a Top 10 cardiac center in 100 days.
Consider this 100-day case study for a Top 10 cardiac center
Consider this 100-day case study
for a Top 10 cardiac center
Consider this 100-day case study
for a Top 10 cardiac center
Consider this 100-day case study
for a Top 10 cardiac center
We are different. While traditional digital agencies use impressions to exaggerate reach, our technology reports new patient registrations and verified billable events to demonstrate tangible ROI.
As a client, you will have 24/7/365 access to an interactive dashboard that provides key performance indicators and real-time patient acquisition funnels. For example, the results above are for a Top 10 cardiac center in 100 days.
We are different. While traditional digital agencies use impressions to exaggerate reach, our technology reports new patient registrations and verified billable events to demonstrate tangible ROI.
As a client, you will have 24/7/365 access to an interactive dashboard that provides key performance indicators and real-time patient acquisition funnels. For example, the results above are for a Top 10 cardiac center in 100 days.
